BRCA2 and ovarian cancer: The ovarian cancer cumulative risk to age 80 years is considerably higher in women with a pathogenic BRCA1 variant compared to those with a pathogenic BRCA2 variant (BRCA1: 44%, BRCA2: 17%) [14].